a clinical trial of sequential tamoxifen and medroxyprogesterone acetate ( mpa ) was carried out in 36 women with metastatic breast cancer in order to evaluate the therapeutic efficacy of this regimen and to determine if tamoxifen would increase progesterone receptor ( pr ) levels and thereby increase response to mpa .
C0065864
medroxyprogesterone acetate
C0025147
mpa